4.11.24
Bio-Europe Fall in Stockholm

24.9.24
Team Building Event & Leadership Transition Announcement.

5.7.24
1st International AL Amyloidosis meeting

Amyl Therapeutics had joined the 2024 AD/PD conference in Lisbon to learn about progress with Immunotherapeutics targeting abeta, TAU and alpha syn and also to consolidate exciting collaborations with research and development teams involved in in vitro and exvivo assays and models in neurodegenerative diseases. Exciting time!